戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  complex formed between streptococcal M1 and human fibrinogen.
2 s the RGD572-574 motif in the alpha chain of human fibrinogen.
3 d to SzM sequences and binding of equine and human fibrinogens.
4 ish between glycosylation of the porcine and human fibrinogens.
5                                              Human fibrinogen 1 is homodimeric with respect to its ga
6 ers than their respective control rabbit and human fibrinogens; (2) the clot structure could be made
7                                              Human fibrinogen (340 kDa) is a dimer, with each identic
8 ructure of a recombinant alphaEC domain from human fibrinogen-420 has been determined at a resolution
9                                              Human fibrinogen-420, (alpha(E)betagamma)(2), was isolat
10                   The FS consisted of pooled human fibrinogen (60 mg/mL) and thrombin (500 NIH U/mL).
11                          About 25-30% of the human fibrinogen Aalpha chains are phosphorylated in nat
12  These results indicate that both bovine and human fibrinogen alpha C-domains consist of a compact gl
13 ture and self-association of the full-length human fibrinogen alphaC-domains.
14                            Citrullination of human fibrinogen and alpha-enolase by P gingivalis was s
15  forms against several substrates, including human fibrinogen and beta-chain insulin, was the Ser-1-G
16 wild-type (wt) streptococcal protease toward human fibrinogen and bovine casein.
17 y inactivated preparation of highly purified human fibrinogen and human thrombin that includes aproti
18                                     Purified human fibrinogen and peptides containing the sequence Ar
19                          The requirement for human fibrinogen and plasminogen as key cofactors was al
20 nhibited the binding in vitro of S. mitis to human fibrinogen and platelets.
21      We now demonstrate that Srr2 also binds human fibrinogen and that this interaction promotes GBS
22 ifically homotypic, because immobilized BSA, human fibrinogen, and fibronectin cannot substitute for
23 d over the course of thrombin reactions with human fibrinogen are only half of what would be expected
24   These results indicate that an RGD site in human fibrinogen at either position alpha252-254 or posi
25  this study we have examined the cleavage of human fibrinogen by tryptase.
26 te at position 572-574 on the alpha chain of human fibrinogen can bind to alphavbeta3.
27 function could not be restored by FReDs from human fibrinogen chain genes.
28 ng the genomic sequence for one of the three human fibrinogen chains controlled by sheep whey protein
29 d by a crystal structure of the D-dimer from human fibrinogen cocrystallized with GHRPYam, the packin
30 iologic concentrations of 0.15 to 0.5 mg/mL, human fibrinogen dose-dependently enhanced by threefold
31 d to support human leukocyte adhesion, while human fibrinogen enhanced monocytic cell attachment to r
32     Here, we investigate the hypothesis that human fibrinogen (FBG) - an acute phase reactant - inhib
33 epidermidis that binds to the Bbeta chain of human fibrinogen (Fg) and is necessary and sufficient fo
34 e dynamics of bovine serum albumin (BSA) and human fibrinogen (Fg) at low concentrations were observe
35      A ligand screen revealed that Bbp binds human fibrinogen (Fg) but not Fg from other mammals.
36 ach at a resolution of 2.8 A, of recombinant human fibrinogen fragment D (rfD) in the absence and pre
37   Analysis of N-glycan mixtures derived from human fibrinogen further demonstrated that AP MALDI-FT I
38            The C-terminal dodecapeptide from human fibrinogen gamma-chain, residues 400-411, HHLG-GAK
39                                              Human fibrinogen gamma-module comprising residues gamma1
40                             Mutations in the human fibrinogen genes can lead to the absence of circul
41 se sequences are nearly identical to the two human fibrinogen glycopeptides, Val-Glu-Asn(CHO)-Lys (ga
42 ctin screen was performed on the porcine and human fibrinogen glycoproteins.
43                       A crystal structure of human fibrinogen has been determined at approximately 3.
44 ructure of a core fragment (fragment D) from human fibrinogen has now been determined to 2.9 A resolu
45 n of the A alpha chain (residues 220-610) of human fibrinogen have been hampered by the difficulty of
46 tropicity, and many of these strains express human fibrinogen (hFg) binding Pattern A-C M-proteins, e
47                     Binding of hPg to either human fibrinogen (hFg) or PAM greatly enhanced activatio
48  is a recently identified subclass of normal human fibrinogen in which two extended alpha chain isofo
49 analysis revealed that pronounced binding of human fibrinogen is a common phenotype of human S. equi
50                                              Human fibrinogen is a homodimer composed of three differ
51 results suggest that SzM-mediated binding of human fibrinogen is an important virulence mechanism of
52                      Furthermore, binding of human fibrinogen is associated with specific SzM types.
53                   The ability of GBS to bind human fibrinogen is of crucial importance in promoting c
54 ys measuring whole-cell S. aureus binding to human fibrinogen, MAb 12-9 inhibited S. aureus binding b
55                      Furthermore, a chimeric human fibrinogen molecule with an RGD sequence at the bo
56 eek fetal liver were nicotinamide deaminase, human fibrinogen-related protein and alpha-acid glycopro
57   We hypothesized that the alpha C-domain of human fibrinogen (residues hA alpha 221-610) and of othe
58 he beta- and gamma-chain carboxyl domains of human fibrinogen revealed that the binding cleft is esse
59                  Further characterization of human fibrinogens showed that Hcys fibrin had similar pl
60 ure of AHRPam complexed with fragment D from human fibrinogen shows that AHRPam binds exclusively to
61  founder animal demonstrated the presence of human fibrinogen subunits at concentrations of 2000 micr
62                        We made a recombinant human fibrinogen that lacks the gamma chain C-terminal f
63             We have targeted expression of r-human fibrinogen to the mammary gland of transgenic mice
64 ydrogen/deuterium exchange profile of native human fibrinogen under physiologic conditions.
65 Aalpha251 matrix and matrices generated from human fibrinogen variants lacking the alphaC regions sup
66 ystem organ microthrombi study in which 125I-human fibrinogen was injected 30 min prior to an endotox
67 the gamma or gamma' chains, respectively, of human fibrinogen were expressed in yeast (Pichia pastori
68  wild-type strain cleaved the alpha chain of human fibrinogen, whereas a cspA mutant, TOH121, was una
69                           We now report that human fibrinogen, which is known not to bind APRP, binds